Myomo vs SS Innovations International
SS Innovations International reported revenue of $42 million in fiscal 2025, about the same as Myomo's $41 million in fiscal 2025. Myomo's revenue grew 25.7% in its latest year, and SS Innovations International's grew 105.7%. Myomo had an operating margin of -35.2%, against -19.3% at SS Innovations International. Free cash flow was −$16 million at Myomo and −$22 million at SS Innovations International.
Side by side
| Myomo | SS Innovations International | |
|---|---|---|
| Latest fiscal year | FY2025, Dec 31, 2025 | FY2025, Dec 31, 2025 |
| Revenue | $41M | $42M |
| Revenue growth | 25.7% | 105.7% |
| Revenue growth a year, last 5 years | 40.0% | — |
| Gross margin | 65.7% | 46.0% |
| Operating margin | −35.2% | −19.3% |
| Net margin | −38.0% | −28.6% |
| Free cash flow | −$16M | −$22M |
| Free cash flow margin | −39.7% | −52.3% |
| Return on capital | — | — |
| Net debt to EBITDA | — | — |
| Dividends and buybacks | $0M | $0M |
| Change in diluted share count | 10.8% | 9.7% |
| Last close | $0.84 | $1.28 |
| P/E at the last close | — | — |
| Insider trades, last 12 months | bought $439,324, sold $102,893 | bought $5.2 million, sold $99,999 |
| Piotroski F-score | 3 of 9 | — |
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.
Ten years
Revenue
US$ billions, fiscal years
MyomoSS Innovations International
Operating margin
Percent of revenue
MyomoSS Innovations International
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
MyomoSS Innovations International
Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Myomo and SS Innovations International pages.